Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Brian W. Bernish"'
Autor:
Jessica Swanner, Cale D. Fahrenholtz, Iliana Tenvooren, Brian W. Bernish, James J. Sears, Allison Hooker, Cristina M. Furdui, Elizabeth Alli, Wencheng Li, George L. Donati, Katherine L. Cook, Pierre‐Alexandre Vidi, Ravi Singh
Publikováno v:
FASEB BioAdvances, Vol 1, Iss 10, Pp 639-660 (2019)
Abstract Silver nanoparticles (AgNPs) show promise for treatment of aggressive cancers including triple‐negative breast cancer (TNBC) in preclinical cancer models. For clinical development of AgNP‐based therapeutics, it will be necessary to clear
Externí odkaz:
https://doaj.org/article/08194cb37e6d42569e52b2e97a9fcfdd
Autor:
George L. Donati, Pierre-Alexandre Vidi, Katherine L. Cook, Allison Hooker, Iliana Tenvooren, Ravi Singh, Wencheng Li, Cristina M. Furdui, Brian W. Bernish, Jessica Swanner, Elizabeth Alli, Cale D. Fahrenholtz, James Sears
Publikováno v:
FASEB BioAdvances, Vol 1, Iss 10, Pp 639-660 (2019)
FASEB bioAdvances
FASEB bioAdvances
Silver nanoparticles (AgNPs) show promise for treatment of aggressive cancers including triple‐negative breast cancer (TNBC) in preclinical cancer models. For clinical development of AgNP‐based therapeutics, it will be necessary to clearly define
Autor:
Mu Yang, Ulrich Bierbach, Ravi Singh, Xiyuan Yao, Michael D. Gross, Ye Zheng, Cale D. Fahrenholtz, Brian W. Bernish, Song Ding, George L. Donati, Mariah Wright
Publikováno v:
Journal of Inorganic Biochemistry. 165:170-180
A three-component drug-delivery system has been developed consisting of multi-walled carbon nanotubes (MWCNTs) coated with a non-classical platinum chemotherapeutic agent ([PtCl(NH3)2(L)]Cl (P3A1; L = N-(2-(acridin-9-ylamino)ethyl)-N-methylproprionim
Glioblastoma multiforme (GBM) is the most common and most lethal primary brain tumor with a 5 year overall survival rate of approximately 5%. Currently, no therapy is curative and all have significant side effects. Focal thermal ablative therapies ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbce601ea179e29ae3aca90810243cc
https://europepmc.org/articles/PMC5082186/
https://europepmc.org/articles/PMC5082186/
Autor:
Lucas P. Neff, Bryan W. Tillman, Brian W. Bernish, Saami K. Yazdani, Randolph L. Geary, Shay Soker, George J. Christ, Masood A. Machingal, James J. Yoo
Publikováno v:
Journal of Vascular Surgery. 53(2):426-434
ObjectivesThere is significant room for improvement in the development of tissue-engineered blood vessels (TEBVs) for vascular reconstruction. Most commonly, TEBVs are seeded with endothelial cells (ECs) only. This provides an antithrombogenic surfac
Publikováno v:
Cancer Research. 77:B37-B37
Glioblastoma multiforme (GBM) is the most common and most lethal primary brain tumor with a 5 year overall survival rate of approximately 5%. Currently, no therapy is curative and all have significant side effects. Focal thermal ablative therapies th
Autor:
Iliana Tenvooren, Brian W. Bernish, Jessica Swanner, Ravi Singh, Katherine L. Cook, Pierre A. Vidi, Cale D. Fahrenholtz
Publikováno v:
Cancer Research. 77:B47-B47
Triple negative breast cancers (TNBC) are characterized by loss of expression of hormone receptors and decreased expression of the human epidermal growth factor receptor 2 (HER2). TNBC patients do not benefit from current targeted breast cancer (BC)
Publikováno v:
Molecular Cancer Research. 14:B05-B05
Triple-negative breast cancer (TNBC) accounts for 10-15% of breast cancers, has the highest levels of recurrence, and the lowest five-year survival of all breast cancer subtypes. TNBC does not express estrogen or progesterone receptors and does not o
Publikováno v:
The FASEB Journal. 25